Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367667075> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4367667075 endingPage "56" @default.
- W4367667075 startingPage "40" @default.
- W4367667075 abstract "Background
 The novel coronavirus disease-2019 (COVID-19), which is caused by Severe Acute Respiratory Distress Syndrome coronavirus 2 (SARS-CoV2), was originally detected in Wuhan, China in December 2019. In this meta-analysis and literature review, we compared and summarized the clinical presentation, cerebrospinal fluid (CSF) and electromyography (EMG) findings and outcomes in SARS-CoV-2 patients with Guillain-Barre Syndrome (GBS) and its variants.
 Methods
 We conducted a literature review in February 2023 searching for terms “Guillain-Barre Syndrome and COVID-19, “SARS neurology”, “COVID-19 complications”. We used PubMed and Google Scholar databases inquiring case reports or series of cases published between April 1, 2020, and September 14, 2023.
 Results
 Of the 52 GBS cases 61,5% (n=32) were male and 39,5% (n=20) were female. The mean age was 57 years old. A total of 75% (n=33) patients presented acute inflammatory demyelinating polyneuropathy (AIDP) variant, 6,8% (n=3) presented acute motor axonal neuropathy (AMAN) variant, 15,9% (n=7) presented acute motor-sensory axonal neuropathy (AMSAN) variant. A total of 85,7% (n=42) of patients were diagnosed with albuminocytological dissociation. During the hospitalization, a total of 30,8% (n=16) required mechanical ventilation. A total of 61,5% (n=32) of patients were treated with a 5-day regimen of intravenous immunoglobulin (IVIG) in dose 0.4 g/kg/day. There were 46,1% (n=24) complete recoveries from GBS, 32,7% (n=17) partial recoveries and 9,6% (n=5) of patients did not respond to treatment. A total of 11,5% (n=6) of patients died.
 Conclusion
 It is crucial to follow patients with COVID-19 and GBS over time to estimate properly the efficacy of treatment and evaluate the real percentage of recovery and complications." @default.
- W4367667075 created "2023-05-03" @default.
- W4367667075 creator A5012053280 @default.
- W4367667075 creator A5023594894 @default.
- W4367667075 creator A5055126194 @default.
- W4367667075 creator A5058147432 @default.
- W4367667075 creator A5059021769 @default.
- W4367667075 creator A5078791887 @default.
- W4367667075 creator A5046366607 @default.
- W4367667075 creator A5072820082 @default.
- W4367667075 date "2023-05-02" @default.
- W4367667075 modified "2023-09-27" @default.
- W4367667075 title "Guillain-Barre Syndrome linked to SARS-CoV-2 infection – meta-analysis and literature review" @default.
- W4367667075 doi "https://doi.org/10.12775/jehs.2023.25.01.004" @default.
- W4367667075 hasPublicationYear "2023" @default.
- W4367667075 type Work @default.
- W4367667075 citedByCount "0" @default.
- W4367667075 crossrefType "journal-article" @default.
- W4367667075 hasAuthorship W4367667075A5012053280 @default.
- W4367667075 hasAuthorship W4367667075A5023594894 @default.
- W4367667075 hasAuthorship W4367667075A5046366607 @default.
- W4367667075 hasAuthorship W4367667075A5055126194 @default.
- W4367667075 hasAuthorship W4367667075A5058147432 @default.
- W4367667075 hasAuthorship W4367667075A5059021769 @default.
- W4367667075 hasAuthorship W4367667075A5072820082 @default.
- W4367667075 hasAuthorship W4367667075A5078791887 @default.
- W4367667075 hasBestOaLocation W43676670751 @default.
- W4367667075 hasConcept C118552586 @default.
- W4367667075 hasConcept C126322002 @default.
- W4367667075 hasConcept C16568411 @default.
- W4367667075 hasConcept C187212893 @default.
- W4367667075 hasConcept C2777080012 @default.
- W4367667075 hasConcept C2777698862 @default.
- W4367667075 hasConcept C2778691916 @default.
- W4367667075 hasConcept C2779134260 @default.
- W4367667075 hasConcept C2779651940 @default.
- W4367667075 hasConcept C2991859549 @default.
- W4367667075 hasConcept C2993568657 @default.
- W4367667075 hasConcept C3008058167 @default.
- W4367667075 hasConcept C524204448 @default.
- W4367667075 hasConcept C71924100 @default.
- W4367667075 hasConceptScore W4367667075C118552586 @default.
- W4367667075 hasConceptScore W4367667075C126322002 @default.
- W4367667075 hasConceptScore W4367667075C16568411 @default.
- W4367667075 hasConceptScore W4367667075C187212893 @default.
- W4367667075 hasConceptScore W4367667075C2777080012 @default.
- W4367667075 hasConceptScore W4367667075C2777698862 @default.
- W4367667075 hasConceptScore W4367667075C2778691916 @default.
- W4367667075 hasConceptScore W4367667075C2779134260 @default.
- W4367667075 hasConceptScore W4367667075C2779651940 @default.
- W4367667075 hasConceptScore W4367667075C2991859549 @default.
- W4367667075 hasConceptScore W4367667075C2993568657 @default.
- W4367667075 hasConceptScore W4367667075C3008058167 @default.
- W4367667075 hasConceptScore W4367667075C524204448 @default.
- W4367667075 hasConceptScore W4367667075C71924100 @default.
- W4367667075 hasIssue "1" @default.
- W4367667075 hasLocation W43676670751 @default.
- W4367667075 hasLocation W43676670752 @default.
- W4367667075 hasOpenAccess W4367667075 @default.
- W4367667075 hasPrimaryLocation W43676670751 @default.
- W4367667075 hasRelatedWork W1977784959 @default.
- W4367667075 hasRelatedWork W2327881589 @default.
- W4367667075 hasRelatedWork W3031154623 @default.
- W4367667075 hasRelatedWork W3130700303 @default.
- W4367667075 hasRelatedWork W3158942431 @default.
- W4367667075 hasRelatedWork W3179862859 @default.
- W4367667075 hasRelatedWork W3200576072 @default.
- W4367667075 hasRelatedWork W4283206048 @default.
- W4367667075 hasRelatedWork W4308016238 @default.
- W4367667075 hasRelatedWork W4226063057 @default.
- W4367667075 hasVolume "25" @default.
- W4367667075 isParatext "false" @default.
- W4367667075 isRetracted "false" @default.
- W4367667075 workType "article" @default.